AGENDA
Oncology Investor Conference
December 7-10, 2021

TUESDAY, DECEMBER 7

All Times are EST Time Zone
 

9:00am // OPENING REMARKS 

9:10am // KEYNOTE TALK - Ron DePinho, M.D., Professor of Cancer Biology | Immediate Past President MD Anderson. Topic: A Model for Converting Discovery into Impact

9:40am // Corporate Presentation - Impact Therapeutics

10:00am // Corporate Presentation - ExoProTher

10:20am // Corporate Presentation - Colospan

10:40am // Corporate Presentation - Propella Therapeutics

11:00am // Corporate Presentation - Atrin Pharmaceuticals

11:20am // Corporate Presentation - RubrcYc Therapeutics

11:40am // Corporate Presentation - SIWA Therapeutics

12:00pm // Corporate Presentation - Plus Therapeutics

12:20pm // CRO Sponsor Presentation - Nuvisan

12:40pm // SPEAKER - Wei Zhang, Ph.D., Director, Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center. Topic: Precision Cancer Medicine - Targeting DNA Repair Defects

1:10pm // Corporate Presentation - AIVITA Biomedical 

1:30pm // Corporate Presentation - Maxwell Biosciences

1:50pm // Corporate Presentation - Biocept

2:10pm // Corporate Presentation - KisoJi Biotechnologies

2:30pm // Corporate Presentation - BriaCell Therapeutics

2:50pm // Corporate Presentation - TransCode Therapeutics

3:10pm // Corporate Presentation - TargaZyme

3:30pm // SPEAKER - Corrie Painter, Ph.D., Associate Director of the Broad Institute Cancer Program | Associate Director of Count Me In. Topic:Count Me In: Partnering with Patients to Accelerate the Pace of Discoveries

4:00pm // CLOSING REMARKS

WEDNESDAY, DECEMBER 8

All Times are EST Time Zone

9:00am // OPENING REMARKS 

9:10am // SPEAKER - Alfred Slanetz, Ph.D., President and CEO of Geneius Biotechnology | Former CEO, Bluebird Bio | Board of Directors NFCR. Topic: T-Cell Therapies for Cancer

9:40am // Corporate Presentation - Altamira Therapeutics

10:00am // Corporate Presentation - Curadigm

10:20am // Corporate Presentation - Early Detection

10:40am // Corporate Presentation - SFA Therapeutics

11:00am // Corporate Presentation - Bexion Pharmaceuticals

11:20am // Corporate Presentation - Qu Biologics

11:40am // Corporate Presentation - CytoImmune Therapeutics

12:00pm // Corporate Presentation - Siva Therapeutics

12:20pm // SPEAKERS - Steven Ferguson, Deputy Director, Licensing and Entrepreneurship, NIH. Michael Salgaller, Ph.D., Director of Tech Transfer, NCI | Supervisor, Invention Development and Marketing Unit (IDMU). Topic: Buying into the Buy Side: NIH as an Industry Partner for Your Go-to-Market Strategy

12:50pm // Corporate Presentation - Carina AI

1:10pm // Corporate Presentation - 7 Hills Pharma

1:30pm // Corporate Presentation - Revere Pharmaceuticals

1:50pm // Corporate Presentation - OncoOne

2:10pm // Corporate Presentation - AmMax Bio

2:30pm // Corporate Presentation - Rakovina Therapeutics

2:50pm // Corporate Presentation - Propelle Therapeutics

3:10pm // Corporate Presentation - Nammi Therapeutics

3:30pm // Corporate Presentation - Creatv MicroTech

3:50pm // SPEAKER - Abraham Heifets, Ph.D., CEO and Co-Founder of Atomwise. Topic: World's Largest Prospetive Application of Machine Learning to Small Molecule Hit Discovery

4:20pm // CLOSING REMARKS

THURSDAY, DECEMBER 9

All Times are EST Time Zone

9:00am // OPENING REMARKS 

9:10am // KEYNOTE TALK - Christiana Bardon, M.D., Partner, MPM Capital and MPM Oncology Impact Fund | Co-Managing Partner of BioImpact Capital. Topic: Oncology: The Smartest Investment in Biotech

9:40am // Corporate Presentation - Transcenta

10:00am // Corporate Presentation - Radiopharm Theranostics

10:20am // Corporate Presentation - Silenseed

10:40am // Corporate Presentation - Infinitum Health

11:00am // Corporate Presentation - Monopteros Therapeutics

11:20am // Corporate Presentation - Brooklyn ImmunoTherapeutics

11:40am // Corporate Presentation - Advanced Microbubbles

12:00pm // SPEAKER - Brian Leyland-Jones, M.D., Ph.D., Former Director of Emory and McGill Cancer Centers | CMO, NFCR | Director, The Darwin Foundation. Topic: The Death Of Cancer!

12:30pm // Corporate Presentation - NuVox Pharma

12:50pm // Corporate Presentation - TarMeta BioSciences

1:10pm // Corporate Presentation - Felicitex Therapeutics

1:30pm // Corporate Presentation - SciTech Development

1:50pm // Corporate Presentation - Vivan Therapeutics

2:10pm // Corporate Presentation - Neosoma

2:30pm // Corporate Presentation - GeoVax

2:50 // Corporate Presentation - Kintara Therapeutics

3:10pm // Corporate Presentation - SageMedic

3:30pm // SPEAKER - Phil Freidlander, M.D., Ph.D., Professor of Medicine, Hematology and Medical Oncology, Mt. Sinai. Topic: Recent Development on TILs and Summary Report of Iovance Data

4:00pm // KEYNOTE SPEAKER - Roy Herbst, M.D., Ph.D., Head Medical Oncology, Yale | Former Director, Yale Cancer Center. Topic: Checkpoint Inhibitors

4:30pm // CLOSING REMARKS